Biopsy Devices | Market Insights | Europe (Supplemental) | 2024
The European biopsy device market was negatively impacted by the COVID-19 pandemic. However, overall biopsy procedure volumes will continue to grow marginally through 2032, driven by rise in cancer screenings as well as updated recommendations to screening guidelines. In addition, the ongoing shift from reusable to disposable devices, coupled with improved patient perceptions surrounding biopsy procedures and screening tests, will have a significant positive impact on the market; overall, these factors will support continued market growth during the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biopsy devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2032.
